G. C. Burdge, Metabolism of ??-linolenic acid in humans, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.3, pp.161-168, 2006.
DOI : 10.1016/j.plefa.2006.05.013

N. Salem-jr, B. Litman, H. Y. Kim, and K. Gawrisch, Mechanisms of action of docosahexaenoic acid in the nervous system, Lipids, vol.68, issue.9, pp.945-959, 2001.
DOI : 10.1007/s11745-001-0805-6

A. Leaf, J. X. Kang, and Y. F. Xiao, Fish Oil Fatty Acids as Cardiovascular Drugs, Current Vascular Pharmacology, vol.6, issue.1, pp.11-12, 2008.
DOI : 10.2174/157016108783331286

K. R. Applegate and J. A. Glomset, Computer-based modeling of the conformation and packing properties of docosahexaenoic acid, J Lipid Res, vol.27, pp.658-680, 1986.

G. H. Rao, E. Radha, and J. G. White, Effect of docosahexaenoic acid (DHA) on arachidonic acid metabolism and platelet function, Biochemical and Biophysical Research Communications, vol.117, issue.2, pp.549-555, 1983.
DOI : 10.1016/0006-291X(83)91235-4

N. G. Bazan, D. L. Birkle, and T. S. Reddy, Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina, Biochemical and Biophysical Research Communications, vol.125, issue.2, pp.741-747, 1984.
DOI : 10.1016/0006-291X(84)90601-6

M. Croset, M. Guichardant, and M. Lagarde, Different metabolic behavior of long-chain n???3 polyunsaturated fatty acids in human platelets, Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, vol.961, issue.2, pp.262-269, 1988.
DOI : 10.1016/0005-2760(88)90121-X

M. Croset, A. Sala, G. Folco, and M. Lagarde, Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle, Biochemical Pharmacology, vol.37, issue.7, pp.1275-1280, 1988.
DOI : 10.1016/0006-2952(88)90782-4

M. Tayot and . Lagarde, Metabolic fate of an oral tracer dose of [13C]docosahexaenoic acid triglycerides in the rat, Am J Physiol, vol.270, pp.846-854, 1996.

N. Brossard, M. Croset, S. Normand, J. Pousin, J. Lecerf et al., Human plasma albumin transports [13C]docosahexaenoic acid in two lipid forms to blood cells, J Lipid Res, vol.38, pp.1571-1582, 1997.

D. Lemaitre-delaunay, C. Pachiaudi, M. Laville, J. Pousin, M. Armstrong et al., Blood compartmental metabolism of docosahexaenoic acid (DHA) in humans after ingestion of a single dose of [(13)C]DHA in phosphatidylcholine, J Lipid Res, vol.40, pp.1867-1874, 1999.

. Bartoli, n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation, Am J Clin Nutr, vol.64, pp.297-304, 1996.

S. S. Najjar, A. Scuteri, and E. G. Lakatta, Arterial Aging: Is It an Immutable Cardiovascular Risk Factor?, Hypertension, vol.46, issue.3, pp.454-462, 2005.
DOI : 10.1161/01.HYP.0000177474.06749.98

E. Vericel, M. Croset, P. Sedivy, P. Courpron, M. Dechavanne et al., Platelets and aging I.???Aggregation, arachidonate metabolism and antioxidant status, Thrombosis Research, vol.49, issue.3, pp.49-331, 1988.
DOI : 10.1016/0049-3848(88)90313-1

E. Vericel, C. Rey, C. Calzada, P. Haond, P. H. Chapuy et al., Age-related changes in arachidonic acid peroxidation and glutathione-peroxidase activity in human platelets, Prostaglandins, vol.43, issue.1, pp.75-85, 1992.
DOI : 10.1016/0090-6980(92)90067-4

G. Hecker, J. Utz, R. J. Kupferschmidt, and V. Ullrich, Low levels of hydrogen peroxide enhance platelet aggregation by cyclooxygenase activation, Eicosanoids, vol.4, pp.107-113, 1991.

C. Calzada, E. Vericel, and M. Lagarde, Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation, Biochemical Journal, vol.325, issue.2, pp.495-500, 1997.
DOI : 10.1042/bj3250495

E. Véricel, C. Calzada, P. Chapuy, and M. Lagarde, The influence of low intake of n-3 fatty acids on platelets in elderly people, Atherosclerosis, vol.147, issue.1, pp.187-192, 1999.
DOI : 10.1016/S0021-9150(99)00171-9

M. Croset, E. Véricel, M. Rigaud, M. Hanss, P. Courpron et al., Functions and tocopherol content of blood platelets from elderly people after low intake of purified eicosapentaenoic acid, Thrombosis Research, vol.57, issue.1, pp.57-58, 1990.
DOI : 10.1016/0049-3848(90)90190-N

N. Guillot, E. Caillet, M. Laville, C. Calzada, M. Lagarde et al., Increasing intakes of the long-chain ??-3 docosahexaenoic acid: effects on platelet functions and redox status in healthy men, The FASEB Journal, vol.23, issue.9, pp.2909-2916, 2009.
DOI : 10.1096/fj.09-133421

URL : https://hal.archives-ouvertes.fr/inserm-00387440

C. Calzada, R. Colas, N. Guillot, M. Guichardant, M. Laville et al., Subgram daily supplementation with docosahexaenoic acid protects low-density lipoproteins from oxidation in healthy men, Atherosclerosis, vol.208, issue.2, pp.467-472, 2010.
DOI : 10.1016/j.atherosclerosis.2009.07.049

URL : https://hal.archives-ouvertes.fr/inserm-00416728

S. Mebarek, N. Ermak, A. Benzaria, S. Vicca, M. Dubois et al., Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis, British Journal of Nutrition, vol.130, issue.06, pp.852-858, 2009.
DOI : 10.1016/j.clnu.2006.03.004

URL : https://hal.archives-ouvertes.fr/inserm-00322838

D. W. Goldman, W. C. Pickett, and E. J. , Human neutrophil chemotactic and degranulating activities of leukotriene B5 (LTB5) derived from eicosapentaenoic acid, Biochemical and Biophysical Research Communications, vol.117, issue.1, pp.282-288, 1983.
DOI : 10.1016/0006-291X(83)91572-3

F. Stanke-labesque, P. Molière, J. Bessard, M. Laville, E. Véricel et al., Effect of dietary supplementation with increasing doses of docosahexaenoic acid on neutrophil lipid composition and leukotriene production in human healthy volunteers, British Journal of Nutrition, vol.1210, issue.04, pp.829-833, 2008.
DOI : 10.1079/BJN2003901

URL : https://hal.archives-ouvertes.fr/inserm-00267466

E. Véricel, A. Polette, S. Bacot, C. Calzada, and M. Lagarde, Pro- and antioxidant activities of docosahexaenoic acid on human blood platelets, Journal of Thrombosis and Haemostasis, vol.279, issue.3, pp.566-572, 2003.
DOI : 10.1046/j.1538-7836.2003.00076.x

M. Guichardant, S. Bacot, P. Molière, and M. , Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.75, issue.3, pp.179-182, 2006.
DOI : 10.1016/j.plefa.2006.05.006

A. Catalá, Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions, Chemistry and Physics of Lipids, vol.157, issue.1, pp.1-11, 2009.
DOI : 10.1016/j.chemphyslip.2008.09.004

M. I. Aveldaño and H. Sprecher, Synthesis of hydroxy fatty acids from 4, 7, 10, 13, 16, 19-[1-14C] docosahexaenoic acid by human platelets, J Biol Chem, vol.258, pp.9339-9343, 1983.

C. N. Serhan, M. Arita, S. Hong, and K. Gotlinger, Resolvins, docosatrienes, and neuroprotectins, novel omega-3-derived mediators, and their endogenous aspirin-triggered epimers, Lipids, vol.33, issue.69, pp.1125-1132, 2004.
DOI : 10.1007/s11745-004-1339-7

C. N. Serhan, Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators, Prostaglandins, Leukotrienes and Essential Fatty Acids, vol.79, issue.3-5, pp.157-163, 2008.
DOI : 10.1016/j.plefa.2008.09.012

N. G. Bazan, J. M. Calandria, and C. N. Serhan, Rescue and repair during photoreceptor cell renewal mediated by docosahexaenoic acid-derived neuroprotectin D1, The Journal of Lipid Research, vol.51, issue.8, pp.2018-2031, 2010.
DOI : 10.1194/jlr.R001131

P. Chen, B. Fenet, S. Michaud, N. Tomczyk, E. Véricel et al., Full characterization of PDX, a neuroprotectin/protectin D1 isomer, which inhibits blood platelet aggregation, FEBS Letters, vol.94, issue.21, pp.583-3478, 2009.
DOI : 10.1016/j.febslet.2009.10.004

URL : https://hal.archives-ouvertes.fr/inserm-00429322

P. Chen, E. Véricel, M. Lagarde, and M. Guichardant, Poxytrins, a class of oxygenated products from polyunsaturated fatty acids, potently inhibit blood platelet aggregation, The FASEB Journal, vol.25, issue.1, pp.25-382, 2011.
DOI : 10.1096/fj.10-161836

URL : https://hal.archives-ouvertes.fr/inserm-00517396